News Focus
News Focus
Followers 43
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

Re: dstock07734 post# 521907

Friday, 10/14/2022 6:07:25 PM

Friday, October 14, 2022 6:07:25 PM

Post# of 818765
you obviously dont understand how RA approval works. If a biotech or big pharma thinks it can improve the treatment of a medical indication by new technology as you describe they need to prove efficiency and bring evidence of the efficiency of that new technology for each medical indication. DCVAXL will be approved for the treatment of GBM in case you have not noticed not for other cancer indications such as lung or liver cancer of any kind. For cancer in other organs, new P3 trials have to be started. Anyone who thinks that based on DCVAXL data NWBO will gain approval for other cancer indications outside GBM is living in a fantasy.

Live and learn the basics of biotech.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News